4/AFiled Sep 22, 8:00 PM ET

Orthofix (OFIX) 10% Owner Juniper Investment Buys 310,000 Shares

$OFIX · Orthofix Medical Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Orthofix (OFIX) 10% Owner Juniper Investment Buys 310,000 Shares

What Happened
Juniper Investment Company, LLC — reported as a 10% owner/investment manager — acquired a total of 310,000 Orthofix (OFIX) shares in two open-market purchases (transaction code P). On 2026-09-18 it bought 120,000 shares at an average price of $8.74 ($1,048,716) and on 2026-09-21 it bought 190,000 shares at an average price of $8.86 ($1,683,381), for combined proceeds of approximately $2.73 million. These were purchases (not sales), which represent new buys by an institutional holder.

Key Details

  • Transaction dates and prices:
    • 2026-09-18: 120,000 shares @ $8.74 (total ≈ $1,048,716) — code P (purchase)
    • 2026-09-21: 190,000 shares @ $8.86 (total ≈ $1,683,381) — code P (purchase)
  • Total shares acquired: 310,000; total value ≈ $2,732,097.
  • Filing: AMENDED Form 4 filed 2026-09-23 for report period 2026-09-18 (Accession: 0001794034-26-000007).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1/F2: Prices reported as weighted averages with ranges (F1: $8.65–$8.81; F2: $8.63–$8.98); reporter will provide trade details on request.
    • F3–F5: Juniper Investment is the investment manager of several funds (Juniper Targeted Opportunity Fund, Juniper Multi‑Strategy Fund, Juniper Targeted Opportunities, LP) and disclaims beneficial ownership of fund holdings except to the extent of its pecuniary interest; two individuals (John A. Bartholdson and Alexis P. Michas) are listed as managing members/general partner and similarly disclaim beneficial ownership except for pecuniary interests.
  • No transaction-timeliness code indicating a late filing was shown in the provided excerpt, but the filing is an amendment.

Context

  • These were open-market purchases by an institutional 10% owner/manager, not insider trades by company executives; institutional buys can signal accumulation but are not the same as executive insider sentiment.
  • The filing is amended and includes weighted-average price ranges rather than per-trade detail; the filer states it will provide specific trade details to the issuer or SEC upon request.